Simple and efficient method for the quantification of antiepileptic drugs in human plasma by using magnetic graphene oxide-β-cyclodextrin composite as a sorbent

Future Journal of Pharmaceutical Sciences

Table 4 Comparison of previously published method for brivaracetam, eslicarbazepine acetate, and carbamazepine

Drug	Extraction method	Determination method	LR (μg mL⁻¹)	LOD (ng mL⁻¹)	RSD (%)	Recovery (%)	Ref
Brivaracetam	LLE	UPLC-MS/MS	0.001– 2.00	0.80	5.64–9.69	91.5–108.7	[37]
Brivaracetam	SLE	LC-MS/MS	0.001–0.20	–	1–8.7	91.6–101	[38]
Brivaracetam	LLE	LC-MS/MS	0.16-8.0	39.0	0.59–1.96	95.7–106.5	[39]
Eslicarbazepine acetate	LLE	LC-MS/MS	50.08–15020	–	0.72–4.11		[40]
Eslicarbazepine acetate	SPE-Bond-Elut C₁₈ cartridges	LC-MS/MS	0.050–1.000	–	0.9–6.1	93.2–106.3	[41]
Eslicarbazepine acetate	μSPE-Oasis® HLB	HPLC-DAD	25–100	7.6	1.1–5.6	≥ 93%	[42]
Cabamazepine	LLE	HPLC-UV	0.5–40	250.0	0.53–3.7	97.53–103.58	[43]
Cabamazepine	SPE-sulfur nanoparticles		0.0005–0.2	0.16	2.2–3.7	97.5–101.3	[16]
Cabamazepine	SPE-Oasis® HLB	HPLC-UV	0.10–50	10.0	2.97–10.54	86.37–88.89
Brivaracetam	SPE-MGO/CD	HPLC-UV	0.5–50	28.32	4.63–6.74	81.23–87.61	Present
Eslicarbazepine acetate	SPE-MGO/CD	HPLC-UV	0.1–40	6.14	1.91–2.85	96.62–99.13	Present
Cabamazepine	SPE-MGO/CD	HPLC-UV	0.25–60	14.86	2.48–3.93	91.27–99.07	Present